IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

APIs Will Drive Growth in Contract Manufacturing

7:52 AM MDT | September 25, 2012 | Deepti Ramesh

The manufacture of active pharmaceutical ingredients (APIs) will account for the majority of revenues in the pharmaceutical contract manufacturing industry in the next 10 years, says a recent report by business information provider Visiongain (London). The report predicts that the global market for pharmaceutical contract manufacturing will be worth $47.6 billion in 2012; and between 2011 and 2016, the overall market will grow at a compound annual growth rate of over 6%. API manufacturing formed the largest sector in pharmaceutical contract manufacturing in 2011...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa